Effect of immunosuppression on the immunogenicity of mRNA vaccines to SARS-CoV-2: a prospective cohort study

…, W Kim, MA Paley, M Yang, AB Carvidi… - Annals of internal …, 2021 - acpjournals.org
Background: Patients with chronic inflammatory disease (CID) treated with immunosuppressive
medications have increased risk for severe COVID-19. Although mRNA-based SARS-…

[HTML][HTML] Glucocorticoids and B cell depleting agents substantially impair immunogenicity of mRNA vaccines to SARS-CoV-2

…, AB Carvidi, AA El-Qunni, A Haile, K Huang, B Kinnett… - MedRxiv, 2021 - ncbi.nlm.nih.gov
Background: Individuals with chronic inflammatory diseases (CID) are frequently treated
with immunosuppressive medications that can increase their risk of severe COVID-19. While …

[HTML][HTML] Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30

…, R Hussien, C Thanh, EA Gibson, AB Carvidi… - PLoS …, 2018 - journals.plos.org
HIV-1-infected cells persist indefinitely despite the use of combination antiretroviral therapy (ART),
and novel therapeutic strategies to target and purge residual infected cells in …

Transient loss of detectable HIV-1 RNA following brentuximab vedotin anti-CD30 therapy for Hodgkin lymphoma

…, LE Hogan, B Descours, N Jones, AB Carvidi… - Blood advances, 2018 - Elsevier
Methods The University of California San Francisco (UCSF) Committee on Human Research
approved the study, and written informed consent was obtained. The participant was …

[HTML][HTML] IMPACT OF IMMUNOSUPPRESSIVE THERAPIES ON ANTIBODY DECAY FOLLOWING MRNA VACCINATION TO SARS-COV-2 IN A PROSPECTIVE …

…, M Paley, M Yang, S Burdess, AB Carvidi… - …, 2022 - pesquisa.bvsalud.org
Background: Waning levels of anti-SARS-CoV-2 Spike (S) antibodies, particularly neutralizing,
are associated with the risk of breakthrough infections. The impact of immunosuppression …

Safety and immunogenicity of Towne cytomegalovirus vaccine with or without adjuvant recombinant interleukin-12

…, B Bredt, L Agrillo, D Black, CL Epling, A Carvidi… - Vaccine, 2006 - Elsevier
The Towne, human cytomegalovirus (CMV) vaccine is safe and immunogenic but has not
prevented infection at doses tested to date. We administered 3000pfu Towne CMV vaccine, …

Antigen-specific T cell responses induced by Towne cytomegalovirus (CMV) vaccine in CMV-seronegative vaccine recipients

…, B Bredt, L Agrillo, D Black, CL Epling, A Carvidi… - Journal of clinical …, 2006 - Elsevier
BACKGROUND: Towne cytomegalovirus (CMV) vaccine is safe and immunogenic, though
its protective efficacy has yet to be optimized. OBJECTIVE: Describe antigen-specific T cell …

[HTML][HTML] Cross-tissue transcriptomic analysis leveraging machine learning approaches identifies new biomarkers for rheumatoid arthritis

…, S Yu, N Perlmutter, J Nititham, A Carvidi… - Frontiers in …, 2021 - frontiersin.org
There is an urgent need to identify biomarkers for diagnosis and disease activity monitoring
in rheumatoid arthritis (RA). We leveraged publicly available microarray gene expression …

HIV-1 Infection Abrogates CD8+ T Cell Mitogen-Activated Protein Kinase Signaling Responses

TQ Crawford, LC Ndhlovu, A Tan, A Carvidi… - Journal of …, 2011 - Am Soc Microbiol
… 4B) but instead was driven primarily by the presence of cells refractory to potent PMA+I
stimuli (Fig. 3B). These data suggest that HIV-1 infection, and associated activation levels, may …

Identification of Cell‐Specific Differential DNA Methylation Associated With Methotrexate Treatment Response in Rheumatoid Arthritis

…, HL Quach, DL Quach, A Carvidi… - Arthritis & …, 2023 - Wiley Online Library
Objective We undertook this study to estimate changes in cell‐specific DNA methylation (DNAm)
associated with methotrexate (MTX) response using whole blood samples collected …